# A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation

> **NCT02809105** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 186 (actual)

## Conditions studied

- Chronic Constipation

## Interventions

- **DRUG:** linaclotide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02809105
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-24
- **Primary completion:** 2016-11-14
- **Final completion:** 2017-11-10
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2024-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02809105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02809105, "A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02809105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*